BACKGROUND: Few studies have analyzed factors that influence longitudinal changes in patient-perceived satisfaction during the recovery period following robot-assisted radical prostatectomy (RARP) for prostate cancer. We investigated variables that were associated with patient-perceived satisfaction after RARP using the expanded prostate cancer index composite (EPIC) survey. METHODS: Of 175 men who underwent RARP between 2010 and 2011, 140 men completed the EPIC questionnaire preoperatively and 3, 6 and 12 months postoperatively. On the basis of the EPIC question no. 32 (item number 80), patients were divided into four groups according to the pattern of satisfaction change at postoperative 3 and 12 months: satisfied to satisfied (group 1); satisfied to dissatisfied (group 2); dissatisfied to satisfied (group 3); and dissatisfied to dissatisfied (group 4). Longitudinal changes in EPIC scores over time in each group and differences in EPIC scores of each domain subscale between groups at each follow-up were analyzed. A linear mixed model with generalized estimating equation approach was used to identify independent factors that influence overall satisfaction among repeated measures from same patients. RESULTS: On the basis of the pattern of satisfaction change, groups 1, 2, 3 and 4 had 103 (74.3%), 21 (15.0%), 11 (7.9%) and 5 (2.9%) patients, respectively. The factor that was associated with overall satisfaction was urinary bother (UB) (b ¼ 0.283, 95% confidence interval (0.024, 0.543 ); P ¼ 0.033) adjusted for other factors under consideration. CONCLUSIONS: UB was the independent factor influencing patient-perceived satisfaction after RARP. During post-RARP follow-up, physician should have the optimal management for the patient's UB.
INTRODUCTION
Health-related quality-of-life (HRQOL) issues are becoming as important as cancer control in the treatment of localized prostate cancer. 1 Patients often select primary treatment based on a modality's impact on HRQOL, as the various therapeutic interventions may be accompanied by potential long-term treatmentrelated side effects, such as urinary, bowel and sexual dysfunction, which alter and presumably diminish HRQOL. [2] [3] [4] [5] [6] Satisfaction with treatment outcome among patients with prostate cancer has been shown to be directly impacted by changes in HRQOL. 7 One study found that almost 16 percent of patients previously treated with early stage prostate cancer expressed regret. These men were more likely to have worse general and disease-specific HRQOL when compared with those without regret. 8 Other studies have reported that decisional regret in the treatment of localized prostate cancer increased significantly over time demonstrating the possible impact of treatment side effects on regret 9 , and that regret following robot-assisted radical prostatectomy (RARP) can be independently predicted by a men's age, baseline functional status, perioperative outcomes and postoperative (postop) urinary and erectile function. 10 However, most of these studies [8] [9] [10] examined treatment-related regret, and did not evaluate treatment satisfaction, which is mainly derived from perceived differences between expectations and experience. 11 To date, few studies have reported on detailed factors that influence longitudinal changes in patient-perceived satisfaction during the recovery period following RARP for prostate cancer.
In this study, we analyzed the longitudinal change of patientperceived satisfaction during the recovery period following RARP, and investigated factors that influence overall satisfaction, as assessed by the expanded prostate cancer index composite (EPIC) survey.
MATERIALS AND METHODS

Patients and data collection
Between January 2010 and February 2011, a prospective longitudinal survey on HRQOL was conducted in men who underwent RARP for 1 localized prostate cancer at our institute after obtaining institutional review board approval. EPIC questionnaires were administered after informed consent and collected preoperatively and at 3, 6 and 12 months after surgery.
RARP was performed according to a standardized surgical technique by a single surgeon (IYK). Foley catheter was typically removed on postop day no. 7. No patients in this cohort underwent cystogram before foley catheter removal. Recovery of continence was defined as being completely pad free based on the patient's interview and EPIC question no. 5 (Q5, item number 27). Potency was defined as the ability to achieve penetration and maintain erection in X50% of attempts based on question no. 2 and 3 on sexual health inventory for men regardless of the use of a PDE5 inhibitor. 12, 13 To determine the effect of other factors including postop adverse events and biochemical recurrence (BCR) on patient-perceived satisfaction, medical charts were reviewed for postop adverse events, serial serum PSA during follow-up visits and any additional adjunctive therapy following initial treatment. Patients were considered to have a BCR if two consecutive PSAs were rising and greater than 0.2 ng ml À 1 after radical prostatectomy.
Questionnaire and measurement
The EPIC survey is a robust prostate cancer HRQOL instrument that complements prior instruments by measuring a broad spectrum of urinary, bowel, sexual and hormonal symptoms, thereby providing a unique tool for comprehensive assessment of HRQOL issues important in contemporary prostate cancer management.
14 HRQOL was measured using the 50-item EPIC, a validated, self-administered questionnaire derived from the University of California, Los Angeles Prostate Cancer Index (UCLA-PCI). 15 Multi-item scale scores were transformed linearly to 0-100 scale, with higher scores representing better HRQOL. We excluded hormonal domain from the analysis because this domain specifically measure symptoms related to androgen deprivation therapy and their related bother.
Overall satisfaction was measured with a five-level Likert scale ranging from 'extremely dissatisfied' to 'extremely satisfied' by the response to EPIC Q32 (item number 80). 11 Original responses are recoded into a 100-point scale, with higher scores representing higher levels of satisfaction. Patients responding that they were 'satisfied' or 'extremely satisfied' with their treatment for prostate cancer were classified as satisfied, whereas all other patients were classified as dissatisfied.
11
The patients were grouped according to the pattern of satisfaction change: satisfied at both 3 and 12 months after surgery (Group 1); satisfied at 3 months but dissatisfied at 12 months (Group 2); dissatisfied at 3 months but satisfied at 12 months (Group 3); and dissatisfied at both 3 and 12 months (Group 4). Longitudinal changes in each EPIC domain subscale scores in each group were evaluated and the differences in EPIC scores of each domain subscale were analyzed between groups at each follow-up to assess the factors associated with changes in satisfaction during the follow-up.
Statistical analysis
A repeated measures analysis of variance with a Greenhouse-Geisser correction determined the longitudinal changes of each domain subscale in each group. Correlations of each domain subscale with the degree of overall satisfaction were measured at each follow-up using the Spearman's rank correlation coefficient, and it was also stratified by age. A linear mixed model was performed to identify independent domain subscales that influence overall satisfaction. Parameters of the model were estimated using a generalized estimating equation. All statistical analyses were performed using SPSS 19.0 software (IBM, Somers, NY, USA), and a P-value o0.05 was considered statistically significant.
RESULTS
Patient characteristics
Among 175 men who underwent RARP during the study period, 143 men completed the EPIC questionnaire preoperatively and at 3, 6 and 12 months after surgery. Patients who were treated with adjuvant radiotherapy and/or androgen deprivation therapy (n ¼ 3) were excluded from the analysis. Therefore, the final cohort comprises 140 men. Baseline characteristics of our study cohort are shown in Table 1 . Median age for the entire cohort was 59 years (range 41-77 years). Among the four groups, there were no significant differences with respect to age, body mass index, preoperative PSA, preoperative American Urological Association Symptom Score, race, prostate weight, Gleason's score, pathologic stage or surgical margin status (Table 1) . Overall, 111 (79.3%) and Figure 1 and created by repeated measures analysis of variance test.
Correlations between the degree of overall satisfaction and individual EPIC domain subscale When examined at each follow-up, urinary bother (UB) and sexual bother (SB) showed significant correlation with overall satisfaction during the entire follow-up periods, whereas SB was not correlated with overall satisfaction at postop 3 and 6 months among the patients with older age (460), but became significantly correlated with overall satisfaction at postop 12 months (Table 2) . Correlation between urinary function and UB was high at each follow-up, whereas the correlation between sexual function (SF) and SB was relatively low at postop 3 months, but became higher over time (Figure 2) . In univariate analyses, associations with most factors under consideration were statistically significant (Po0.05). In multivariable modeling, only UB was associated with overall satisfaction adjusted for age, urinary function, UB, bowel bother, bowel function, SF and SB (Table 3) .
Other factors related to overall satisfaction Overall, the rate of postop adverse events was low. Transient urinary retention was reported in 11 patients (8%), bladder neck contracture in 3 patients (2%), paralytic ileus in 2 patients (1.4%), Clostridium difficile colitis in 1 patient (0.7%), lymphocele in 1 patient (0.7%) and pelvic abscess in 1 patient (0.7%). None of these adverse events were statistically associated with overall satisfaction (data not shown). By 1 year after surgery, two patients experienced BCR and they were followed without adjunctive treatment.
DISCUSSION
Although many previous studies have focused on quantifying the burden of prostate cancer treatment with objective measures of HRQOL from the perspective of physicians, [16] [17] [18] [19] [20] [21] there has been a relative paucity of studies that measure patient-reported satisfaction with treatment outcome and HRQOL. [7] [8] [9] [10] [11] Patient-perceived satisfaction about treatment depends on several factors, including functional and oncological outcomes, [7] [8] [9] [10] [11] as well as many other relationship-oriented factors. 22 In addition, patient-perceived distress with dysfunction after treatment can also have a substantial impact on the overall satisfaction with specific treatment. Recently, investigators showed the relationships of several variables to treatment-related regret following RARP. 10 However, the dynamic level of regret with time and important component of the development of decisional regret could not be assessed due to the crosssectional nature of their study. 10 To our knowledge, our study is the first to evaluate dynamic changes of patient-perceived satisfaction over time during the recovery period after RARP based on a validated questionnaire survey administered longitudinally. Also, we identified factors that affect changes over time in patient-perceived satisfaction about the treatment of prostate cancer.
In our study, we found that the majority of men (74.3%) were satisfied at both 3 and 12 months after surgery. Twenty-three percent of patients showed changes in their satisfaction status during follow-up periods; 15% of patients were satisfied during the early postop period but became dissatisfied during the delayed period and 8% of patients were dissatisfied during the early period but eventually became satisfied during the delayed period. We presume that only UB has a substantial impact on patient-perceived satisfaction about the treatment with RARP during the early period follow-up after surgery. Moreover, UB appears to have an impact on patient-perceived satisfaction adjusted for other factors under consideration via multivariate analyses with linear generalized estimating equation.
Our findings demonstrate that bother subscale is a more robust indicator of patient-perceived satisfaction on treatment than functional subscale. Bother scores report the distress experienced by patients as a consequence of functional detriments with the Factors related to satisfaction after RARP JH Kim et al degree to which they consider the detriments problematic. Therefore, the measurement of bother is an important component of understanding patient-reported HRQOL after prostate cancer treatment. Previously, Gore et al. 23 reported that worse function scores were associated with severe urinary, sexual and bowel bother following prostate cancer treatment. However, our findings showed several important disparities with their study. First, function score did not always correlate with bother. Correlation between dysfunction and bother can change depending on the type of dysfunction and distress over time. Urinary function score highly correlates with UB all through the follow-up period, whereas SF score showed a relatively low degree of correlation with SB during the early postop period, although it became well correlated with SB over time. Gacci et al. 24 also reported that although the correlation between urinary function and UB was strongly maintained through the long-term periods, the correlation between SF and SB was modestly maintained for 7 years, after which the function and bother appeared to have divergent trajectories. Second, although Gore et al. 23 reported that the association between function score and severe bother was weakest for the sexual domains, our findings showed strong correlation between SF and SB with longer follow-up, which substantially affected the overall satisfaction during later postop follow-up. In our study, we identified several variables that directly relate to patient-perceived satisfaction following surgery. We found these factors to vary according to the patient's age and length of follow-up.
Surgery-related adverse events were low and two patients (1.4%) had BCR by 1 year after surgery. In spite of statistical verification, we could not conclude any influence of these complications and oncological results on patient-perceived satisfaction due to the small number of patients with complications or BCR. Our study has several more limitations. Certain demographic parameters such as socioeconomic and educational status, which may be associated with patient-perceived satisfaction, were not available in our study. Among this cohort, a risk of selection or nonrespondent bias existed, as not responding to complete a survey could be an indication for dissatisfaction. However, the response rate was high (81.7%) in our study when compared with prior published studies. [8] [9] [10] [11] Low correlation coefficients for all comparisons were also one of the shortcomings in our current study. Therefore, these results should be validated in other independent groups comprising larger population to confirm our current results. Finally, the number of men who showed changes in their satisfaction status during the follow-up periods is relatively small in our study group. Nevertheless, we found consistent results from correlations of overall satisfaction with each EPIC domain subscale and multiple linear regression analysis.
In conclusion, the majority of men (74.3%) were satisfied at both 3 and 12 months following RARP. UB was the most important factor that influenced patient-perceived satisfaction about the treatment during the early recovery period after RARP and continued to influence satisfaction at longer-term follow-up. In this age of information technology, most prostate cancer patients are very familiar with the various outcomes related to HRQOL of RARP. We identified that the UB is the only factor affecting patients-perceived satisfaction adjusted for other factors under consideration. During post-RARP follow-up, physician should especially take care of the patients' UB via optimal treatment. Additional long-term longitudinal follow-up will be needed to corroborate and confirm our findings.
